Description
PT-141 is bremelanotide, a synthetic melanocortin-receptor agonist derived from Melanotan II, used as a reference peptide in melanocortin research. Researchers study it for its selectivity toward central melanocortin pathways.
In cultured cells and laboratory animals, investigations have focused on melanocortin-4-receptor signaling, neurovascular pathways, behavioral responses, and central-nervous-system activity. Its receptor profile makes it a distinct probe for melanocortin research.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.






Reviews
There are no reviews yet.